Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02870387 · ClinicalTrials.gov registry record · NA
Inpatient Consultation for High-Risk Chronically Ill Children Receiving Care in an Enhanced Medical Home
A NA study of Chronic Illnesses, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 342
- Enrollment target
- 1
- Study location
NCT02870387: Completed NA study of Chronic Illnesses, sponsored by The University of Texas Health Science Center, Houston.
NCT02870387 is a NA study of Chronic Illnesses that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 342 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02870387, a NA study of Chronic Illnesses, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 342 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will conduct a pilot quality improvement trial to assess the impact of offering inpatient consultation to further optimize coordination and improve care for high-risk chronically ill children receiving comprehensive care in an enhanced medical home.
Primary Outcome
Total number of hospital days at Children's Memorial Hermann Hospital (CMHH) per child-year
Conditions Studied
Interventions
- OTHER Comprehensive Care with Inpatient consultation
- OTHER Usual Inpatient Care
Study Locations (1)
Texas
- The University of Texas Medical School at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 342 participants |
| Start Date | 2016-10 |
| Est. Completion | 2018-01-26 |
| Phase | NA |
What the finished NCT02870387 record still lists
NCT02870387 is an interventional study that assigns participants to a tested intervention. The registered 342 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Chronic Illnesses appearing as the primary indexed condition, and to 2 interventions - of which Comprehensive Care with Inpatient consultation is the first listed.
NCT02870387 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02870387 about?
NCT02870387 is a clinical study titled "Inpatient Consultation for High-Risk Chronically Ill Children Receiving Care in an Enhanced Medical Home". The investigators will conduct a pilot quality improvement trial to assess the impact of offering inpatient consultation to further optimize coordination and improve care for high-risk chronically ill children receiving comprehensive care in an enhanced medical home.
What is the current status of trial NCT02870387?
This trial is currently completed. It is a NA study. The enrollment target is 342 participants. The study started on 2016-10. Estimated completion is 2018-01-26.
What conditions does trial NCT02870387 study?
This clinical trial studies the following conditions: Chronic Illnesses.
What interventions are being tested in trial NCT02870387?
The interventions under investigation include: Comprehensive Care with Inpatient consultation (OTHER), Usual Inpatient Care (OTHER).
Who is sponsoring clinical trial NCT02870387?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02870387 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Illnesses
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02870387's enrollment target sits among peer trials
342 302nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283850 · 342 participants · Phase 2
Surviving PEA in Roanoke (SPEAR) Study
- NCT05714085 · 342 participants · Phase 2
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- NCT06188702 · 342 participants · Phase 1
S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP
- NCT06544941 · 342 participants · NA
Improving Maternal Sleep and Mental Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia